眼窝填充物取出73例临床分析  

Clinical Analysis of Removing Eyehole Filler(A Report of 73 Cases)

作　　者：宋斗[1] 尤媛[1] 高方[1] 高利雅[1] 

机构地区：[1]解放军117医院眼科,杭州310013

出　　处：《解放军医药杂志》2012年第6期26-28,共3页Medical & Pharmaceutical Journal of Chinese People’s Liberation Army

摘　　要：目的分析眼窝填充物取出的原因,寻找合适的治疗方法和材料。方法对因各种原因取出原有眼窝填充物的73例临床资料进行回顾性分析。结果取出的眼窝填充物材料为硅胶41例,羟基磷灰石19例,Medpor 3例,碳纤维3例,玻璃2例,陶瓷2例,未知材料3例。取出后Ⅰ期植入羟基磷灰石眼座61例,Ⅱ期植入5例,再次植入眼座者均未发生继发感染和义眼座暴露。7例未植入义眼座。结论羟基磷灰石眼座的组织相容性好,是合适的眼窝填充物,对无明显感染的需取出原眼窝填充物者,可在取出后同时植入羟基磷灰石眼座。Objective To analyse reasons that removed eyehole filler and to seek for the appropriate materials and therapeutic methods. Methods We retrospectively analyzed the clinical data of 73 patients who needed the orbital filler to be removed for various reasons. Results The filler material which had been taken out from orbital was silicone in 41 cases, hydroxyapatite in 19 cases, Medpor in 3 cases, carbon fiber in 3 cases, glass in 2 cases, ceramic in 2 cases and unknown materials in 3 cases. Hydroxyapatite was implanted at the time of removing orbital filler in 61 patients. Hydroxyapatite was implanted after 3-months controlled infection in 5 patients. There was no case of secondary infection and implant exposure. 7 patients had not been imbedded with a false eye. Conclusion The hydroxyapatite orbital implant has a good tissue compatibility; it can be used as an appropriate orbital implant. Hydroxyapatite can be implanted at the time of removing an orbital filler for the patients who have no significant infection.

关 键 词：眼 人工 羟基磷灰石类 眼眶植入物 移植物排斥 

分 类 号：R779.64[医药卫生—眼科]